Skip to main content
Equibles
TWST logo

TWST · Twist Bioscience Corp

Track TWST — free

Use TWST with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$128.71 -2.29 (-1.75%) At close · Sep 3
Russell 2000 member Rebalance outlook locked
Market Cap
$8.00B
Shares
62.71M

TWST metrics

69 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$128.71
Market cap
$8.00B

Price action

19 metrics
Price change (1W)
-12.7%
Price change (30D)
+31.7%
Price change (3M)
+81.1%
Price change (6M)
+172.6%
Price change (YTD)
+313.0%
Price change (1Y)
+399.2%
Trailing year
Price change (5Y)
+11.3%
52-week high
$153.10
52-week low
$24.16
Change from 52-week high
-14.4%
Change from 52-week low
+442.2%
Annualized volatility
74.4%
Beta
2.7
RSI (14D)
53.5
Price vs SMA 50
+19.5%
Price vs SMA 200
+105.5%
Avg volume (3M)
1.80M
Relative volume
1.1
Average dollar volume
$183.87M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
62.71M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
18.5×
reciprocal yield 5.4%
P / book
17.9
reciprocal yield 5.6%
FCF yield
-1.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
43.2×
reciprocal yield 2.3%
EV / revenue historical average (5Y)
43.2×
reciprocal yield 2.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
52.0%
Operating margin
-33.6%
Trailing 12 months
Net margin
-31.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$144.98M
Net income (TTM)
−$136.72M
Trailing 12 months
Diluted EPS (TTM)
$-2.21
FCF margin
-21.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-62.83

Growth

11 metrics
Revenue growth YoY
+23.2%
Year over year
Net income growth YoY
-271.9%
Revenue (TTM)
$431.80M
Trailing 12 months
EPS growth YoY
-269.7%
Shares change YoY
+2.0%
Year over year · more shares
Revenue CAGR (3Y)
+22.8%
Revenue CAGR (5Y)
+33.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-30.7%
Return on assets
-20.3%
Debt / equity
—
Current ratio
2.7
EBITDA (TTM)
−$119.59M
Free cash flow (TTM)
−$93.12M
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$117.44M
Total assets
$672.44M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$53.07M
Capital expenditures (TTM)
$40.05M
R&D (TTM)
$71.86M
SG&A (TTM)
$290.29M
Stock compensation (TTM)
$66.47M
R&D / revenue
16.6%
Stock compensation / revenue
15.4%

Ownership (13F)

3 metrics
13F filers
339
13F filer change QoQ
+56
Institutional ownership
122.7%

Short interest

3 metrics
Short interest
22.5%
Latest settlement · 7.9 days to cover
Days to cover
7.9d
Short-squeeze score
84 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$47.39M
Insider-sentiment score
11 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1581280 CUSIP 90184D100 13F (30d) 258 filings 251 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)